Summary:
- This article provides insights into the early-stage biotech venture capital (VC) industry, drawing on the author's 20 years of experience in this field.
- It discusses the evolution of the biotech VC landscape, highlighting the increasing complexity and specialization of the industry over the past two decades.
- The article emphasizes the importance of understanding the unique challenges and opportunities in the biotech sector, as well as the critical role that VC funding plays in supporting the development of innovative medical technologies.